BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26371177)

  • 1. The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota.
    Liechty ER; Bergin IL; Bassis CM; Chai D; LeBar W; Young VB; Bell JD
    Pathog Dis; 2015 Nov; 73(8):ftv070. PubMed ID: 26371177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Levonorgestrel-Releasing Intrauterine System on the Progression of Chlamydia trachomatis Infection to Pelvic Inflammatory Disease in a Baboon Model.
    Eastman AJ; Bergin IL; Chai D; Bassis CM; LeBar W; Oluoch GO; Liechty ER; Nyachieo A; Young VB; Aronoff DM; Patton DL; Bell JD
    J Infect Dis; 2018 Jan; 217(4):656-666. PubMed ID: 29253201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactional changes in short-term levonorgestrel-releasing intrauterine system (lng-ius) use.
    Giraldo PC; Souza TC; Henrique GL; Monteiro I; Amaral R; Machado RB; Discacciati MG; Sanches JM
    Rev Assoc Med Bras (1992); 2019 Jul; 65(6):857-863. PubMed ID: 31340317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a hormone-releasing intrauterine system on the vaginal microbiome: a prospective baboon model.
    Hashway SA; Bergin IL; Bassis CM; Uchihashi M; Schmidt KC; Young VB; Aronoff DM; Patton DL; Bell JD
    J Med Primatol; 2014 Apr; 43(2):89-99. PubMed ID: 24266633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal microbiome changes with levonorgestrel intrauterine system placement.
    Jacobson JC; Turok DK; Dermish AI; Nygaard IE; Settles ML
    Contraception; 2014 Aug; 90(2):130-5. PubMed ID: 24835828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intrauterine contraception on the vaginal microbiota.
    Bassis CM; Allsworth JE; Wahl HN; Sack DE; Young VB; Bell JD
    Contraception; 2017 Sep; 96(3):189-195. PubMed ID: 28624570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.
    Donders GGG; Bellen G; Ruban K; Van Bulck B
    J Med Microbiol; 2018 Mar; 67(3):308-313. PubMed ID: 29458551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
    Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
    Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel-releasing intrauterine system in women without previous vaginal delivery: a RCT.
    Castro TV; Franceschini SA; Poli-Neto O; Ferriani RA; Silva de Sá MF; Vieira CS
    Hum Reprod; 2014 Nov; 29(11):2439-45. PubMed ID: 25240012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of contraceptive choice on vaginal bacterial and fungal microflora.
    Donders G; Bellen G; Janssens D; Van Bulck B; Hinoul P; Verguts J
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):43-48. PubMed ID: 27638008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies.
    Apter D; Gemzell-Danielsson K; Hauck B; Rosen K; Zurth C
    Fertil Steril; 2014 Jun; 101(6):1656-62.e1-4. PubMed ID: 24726226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey.
    Römer T; Linsberger D
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):391-8. PubMed ID: 19929641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial.
    Gemzell-Danielsson K; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Nelson A
    PLoS One; 2015; 10(9):e0135309. PubMed ID: 26378938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS).
    Lessard T; Simões JA; Discacciati MG; Hidalgo M; Bahamondes L
    Contraception; 2008 Jan; 77(1):30-3. PubMed ID: 18082663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
    Heikinheimo O; Lehtovirta P; Suni J; Paavonen J
    Hum Reprod; 2006 Nov; 21(11):2857-61. PubMed ID: 16880227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo.
    Villegas G; Calenda G; Ugaonkar S; Zhang S; Kizima L; Mizenina O; Gettie A; Blanchard J; Cooney ML; Robbiani M; Fernández-Romero JA; Zydowsky TM; Teleshova N
    PLoS One; 2016; 11(7):e0159332. PubMed ID: 27428377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?
    Wildemeersch D; Janssens D; Weyers S
    Maturitas; 2005 Jun; 51(2):207-14. PubMed ID: 15917162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.